Response to the comment on ‘Branched‐chain amino acids and all‐cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients’

Documenti analoghi

• Branched‐chain amino acids and all‐cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients
  di: Yakun Li, et al.
  Pubblicazione: (2025)
• Comment on “Branched‐chain amino acids and all‐cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients”
  di: Rachana Mehta, et al.
  Pubblicazione: (2025)
• Central role of pro‐IGFII(68–88) (big IGFII) in the pathogenesis nonislet cell tumour‐induced hypoglycaemia
  di: Robin P. F. Dullaart
  Pubblicazione: (2024)
• Adiponectin as a biomarker in liver cirrhosis—A systematic review and meta‐analysis
  di: Abdulrahman Ismaiel, et al.
  Pubblicazione: (2024)
• Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study
  di: Caecilia S. E. Doorenbos, et al.
  Pubblicazione: (2025)